Characterization of a C3/C3b regulatory protein in normal human serum
- 1 March 1980
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 96 (3) , 564-568
- https://doi.org/10.1016/s0022-3476(80)80867-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- ANTIBODY AND COMPLEMENT-MEDIATED CYTOTOXICITY OF NUCLEATED CELLS INHIBITION BY THE SERA OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIATransplantation, 1978
- Human C4-binding protein. I. Isolation and characterizationThe Journal of Experimental Medicine, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejectionImmunochemistry, 1976
- Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.The Journal of Experimental Medicine, 1975
- FORMATION OF A HEMOLYTICALLY ACTIVE CELLULAR INTERMEDIATE BY THE INTERACTION BETWEEN PROPERDIN FACTORS B AND D AND THE ACTIVATED THIRD COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1973
- INHIBITION OF C3 CONVERSION AFTER ALLOTRANSPLANTATIONTransplantation, 1972
- THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASEThe Journal of Experimental Medicine, 1968
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965